Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Neuropsychiatric Disease and Treatment|April 20, 2022
Practical Advice for Primary Care Clinicians on the Safe and Effective Use of Vortioxetine for Patients with Major Depressive Disorder (MDD)C Brendan Montano, W Clay Jackson, Denise Vanacore, et al.
CNS Spectrums|December 14, 2005
Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHDRichard H Weisler, Joseph Biederman, Thomas J Spencer, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|December 13, 2006
Bipolar II disorder: current and future treatment optionsRif El-Mallakh, Richard H Weisler, Mark H Townsend, et al.
The Journal of Clinical Psychiatry|November 8, 2011
Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study)Richard H Weisler, Willem A Nolen, Anders Neijber, et al.
The Journal of Clinical Psychiatry|May 3, 2006
Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled studyRobert M A Hirschfeld, Richard H Weisler, Shane R Raines, et al.
The Journal of Clinical Psychiatry|November 18, 2008
Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled studyThomas J Spencer, Lenard A Adler, Richard H Weisler, et al.
CNS Spectrums|December 14, 2005
An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHDDavid W Goodman, Lawrence Ginsberg, Richard H Weisler, et al.
CNS Drugs|April 24, 2012
Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorderRichard H Weisler, Gahan J Pandina, Ella J Daly, et al.
Psychiatry (Edgmont (Pa. : Township))|July 11, 2012
Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I DisorderRichard H Weisler, Amir H Kalali, Andrew J Cutler, et al.
Psychopharmacology|December 13, 2005
Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatmentKathryn M Connor, Jonathan R T Davidson, Richard H Weisler, et al.
Pageof 6